Lab Volume Index

XIFIN analyzed its vast stores of data, representative of four out of five top integrated delivery networks (IDNs) and seven out of the top ten independent laboratories nationwide, to craft the Lab Volume Index. Currently, XIFIN sees 20 - 25% of all COVID-19 and antibody testing claims nationwide. The Lab Volume Index synthesizes billing volume data into a measurement of testing volumes as compared to a pre-Coronavirus testing average ("baseline").

NEW: Antibody testing has risen in volume in recent weeks and is now broken out separately in the segment analysis.  

Updated 5/27/20 10:46 AM PDT

 

Receive Timely Updates about COVID-19

XIFIN analyzes millions of accessions/visits to provide cross-industry impacts caused by COVID-19. Sign up for email updates and we’ll send timely, data-driven insights right to your inbox.

XIFIN Laboratory Volume Index as of May 24, 2020
XIFIN Laboratory Testing Volume as of May 24, 2020

The Lab Volume Index measures billing volume data against a baseline volume, expressed as a percent of baseline. Baseline volume is an average of weekly volumes generated late January through February 2020, and represents current year pre-Coronavirus testing volumes. 

COVID-19 Resources from XIFIN

XIFIN’s COVID-19 Laboratory Resource Center is designed to keep you updated on COVID-19 matters affecting laboratories, including the latest on testing, testing supply needs, and payor billing requirements.

View Now
COVID-19 Resources from XIFIN

XIFIN’s COVID-19 Laboratory Resource Center is designed to keep you updated on COVID-19 matters affecting laboratories, including the latest on testing, testing supply needs, and payor billing requirements.

View Now